CONTEXT: Serotonin 1A (5-hydroxytryptamine 1A [5-HT(1A)]) autoreceptors mediate negative feedback inhibition of serotonergic neurons and play a critical role in regulating serotonin signaling involved in shaping the functional response of major forebrain targets, such as the amygdala, supporting complex behavioral processes. A common functional variation (C[-1019]G) in the human 5-HT(1A) gene (HTR1A) represents 1 potential source of such interindividual variability. Both in vitro and in vivo, -1019G blocks transcriptional repression, leading to increased autoreceptor expression. Thus, -1019G may contribute to relatively decreased serotonin signaling at postsynaptic forebrain target sites via increased negative feedback. OBJECTIVES: To evaluate the effects of HTR1A C(-1019)G on amygdala reactivity and to use path analyses to explore the impact of HTR1A-mediated variability in amygdala reactivity on individual differences in trait anxiety. We hypothesized that -1019G, which potentially results in decreased serotonin signaling, would be associated with relatively decreased amygdala reactivity and related trait anxiety. DESIGN: Imaging genetics in participants from an archival database. PARTICIPANTS: Eighty-nine healthy adults. RESULTS: Consistent with prior findings, -1019G was associated with significantly decreased threat-related amygdala reactivity. Importantly, this effect was independent of that associated with another common functional polymorphism that affects serotonin signaling, 5-HTTLPR. While there were no direct genotype effects on trait anxiety, HTR1A C(-1019)G indirectly predicted 9.2% of interindividual variability in trait anxiety through its effects on amygdala reactivity. CONCLUSIONS: Our findings further implicate relatively increased serotonin signaling, associated with a genetic variation that mediates increased 5-HT(1A) autoreceptors, in driving amygdala reactivity and trait anxiety. Moreover, they provide empirical documentation of the basic premise that genetic variation indirectly affects emergent behavioral processes related to psychiatric disease risk by biasing the response of underlying neural circuitries.
CONTEXT: Serotonin 1A (5-hydroxytryptamine 1A [5-HT(1A)]) autoreceptors mediate negative feedback inhibition of serotonergic neurons and play a critical role in regulating serotonin signaling involved in shaping the functional response of major forebrain targets, such as the amygdala, supporting complex behavioral processes. A common functional variation (C[-1019]G) in the human5-HT(1A) gene (HTR1A) represents 1 potential source of such interindividual variability. Both in vitro and in vivo, -1019G blocks transcriptional repression, leading to increased autoreceptor expression. Thus, -1019G may contribute to relatively decreased serotonin signaling at postsynaptic forebrain target sites via increased negative feedback. OBJECTIVES: To evaluate the effects of HTR1A C(-1019)G on amygdala reactivity and to use path analyses to explore the impact of HTR1A-mediated variability in amygdala reactivity on individual differences in trait anxiety. We hypothesized that -1019G, which potentially results in decreased serotonin signaling, would be associated with relatively decreased amygdala reactivity and related trait anxiety. DESIGN: Imaging genetics in participants from an archival database. PARTICIPANTS: Eighty-nine healthy adults. RESULTS: Consistent with prior findings, -1019G was associated with significantly decreased threat-related amygdala reactivity. Importantly, this effect was independent of that associated with another common functional polymorphism that affects serotonin signaling, 5-HTTLPR. While there were no direct genotype effects on trait anxiety, HTR1A C(-1019)G indirectly predicted 9.2% of interindividual variability in trait anxiety through its effects on amygdala reactivity. CONCLUSIONS: Our findings further implicate relatively increased serotonin signaling, associated with a genetic variation that mediates increased 5-HT(1A) autoreceptors, in driving amygdala reactivity and trait anxiety. Moreover, they provide empirical documentation of the basic premise that genetic variation indirectly affects emergent behavioral processes related to psychiatric disease risk by biasing the response of underlying neural circuitries.
Authors: A Strobel; L Gutknecht; C Rothe; A Reif; R Mössner; Y Zeng; B Brocke; K-P Lesch Journal: J Neural Transm (Vienna) Date: 2003-01-01 Impact factor: 3.575
Authors: Leah H Somerville; Hackjin Kim; Tom Johnstone; Andrew L Alexander; Paul J Whalen Journal: Biol Psychiatry Date: 2004-05-01 Impact factor: 13.382
Authors: Alexander Neumeister; Earle Bain; Allison C Nugent; Richard E Carson; Omer Bonne; David A Luckenbaugh; William Eckelman; Peter Herscovitch; Dennis S Charney; Wayne C Drevets Journal: J Neurosci Date: 2004-01-21 Impact factor: 6.167
Authors: Sylvie Lemonde; Gustavo Turecki; David Bakish; Lisheng Du; Pavel D Hrdina; Christopher D Bown; Adolfo Sequeira; Neena Kushwaha; Stephen J Morris; Ajoy Basak; Xiao-Ming Ou; Paul R Albert Journal: J Neurosci Date: 2003-09-24 Impact factor: 6.167
Authors: Nesha S Burghardt; Gregory M Sullivan; Bruce S McEwen; Jack M Gorman; Joseph E LeDoux Journal: Biol Psychiatry Date: 2004-06-15 Impact factor: 13.382
Authors: Helena Cousijn; Mark Rijpkema; Shaozheng Qin; Hein J F van Marle; Barbara Franke; Erno J Hermans; Guido van Wingen; Guillén Fernández Journal: Proc Natl Acad Sci U S A Date: 2010-05-10 Impact factor: 11.205
Authors: Elizabeth P Hayden; Daniel N Klein; Haroon I Sheikh; Thomas M Olino; Lea R Dougherty; Margaret W Dyson; C Emily Durbin; Shiva M Singh Journal: Emotion Date: 2010-10
Authors: Emily B Falk; Luke W Hyde; Colter Mitchell; Jessica Faul; Richard Gonzalez; Mary M Heitzeg; Daniel P Keating; Kenneth M Langa; Meghan E Martz; Julie Maslowsky; Frederick J Morrison; Douglas C Noll; Megan E Patrick; Fabian T Pfeffer; Patricia A Reuter-Lorenz; Moriah E Thomason; Pamela Davis-Kean; Christopher S Monk; John Schulenberg Journal: Proc Natl Acad Sci U S A Date: 2013-10-22 Impact factor: 11.205
Authors: Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David Journal: Neuroscientist Date: 2014-12-08 Impact factor: 7.519